SPHYGMOMANOMETER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Sphygmomanometer Market Size and Trends

Global sphygmomanometer market is estimated to be valued at USD 3.92 Bn in 2024 and is expected to reach USD 7.20 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2024 to 2031.

Discover market dynamics shaping the industry request sample copy

Global sphygmomanometer market is expected to witness positive growth over the forecast period owing to increasing prevalence of hypertension across the globe. According to the World Health Organization (WHO)’s Press Release published in August 2021, the number of persons aged 30-79 years with hypertension has increased from 650 million to 1.28 billion in the previous 30 years,. Growing geriatric population susceptible to blood pressure issues is further expected to boost its demand. Additionally, technological advancements in sphygmomanometers including integration of Bluetooth and WiFi in devices for remote monitoring will support the market expansion through 2031. However, availability of alternative blood pressure monitors can hamper growth of sphygmomanometer market during the forecast period.

Growing awareness of importance of blood pressure monitoring

With increasing prevalence of hypertension and cardiovascular diseases, awareness about regular blood pressure monitoring has grown significantly among general population worldwide. Hypertension has become one of the major risk factors for heart attacks, strokes, kidney failures and other serious health conditions. Regular monitoring and management of blood pressure levels is considered important to prevent or delay the onset of such diseases. People are now more informed about normal blood pressure ranges and risks of uncontrolled high blood pressure. This has resulted in increased uptake of home blood pressure monitoring devices. Sphygmomanometers offer a convenient and affordable means for self and household BP monitoring. Rising health consciousness and focus on preventive healthcare is driving more customers towards these devices.

Market Concentration and Competitive Landscape

Get actionable strategies to beat competition: Get instant access to report

Ageing population globally has become an important demographic and social trend in recent decades. Medical experts warn that risk of hypertension and associated complications increases with older age. At the same time, lifestyle diseases have risen manifold due to changing dietary patterns and more sedentary habits in modern lifestyle. Developed nations already have a significantly older population structure. Even developing countries are witnessing a sharp rise in their geriatric population base as life expectancy increases. This elderly segment of society is more prone to developing age-related health conditions like hypertension. Regular medical supervision and home monitoring is important for effective management. This makes sphygmomanometers an essential healthcare product within this demographic. With greater numbers of elderly worldwide, the demand for self blood pressure monitors is expected to see sustained demand. Manufacturers are accordingly developing more user-friendly products tailored for the senior population.

To learn more about this report, request sample copy

Accuracy and reliability issues are one of the major constraints affecting the expansion of the sphygmomanometer market. Sphygmomanometers are medical devices used to measure blood pressure, and even minor inaccuracies in readings can lead to incorrect diagnosis and treatment decisions by healthcare professionals. Several independent clinical studies conducted on various brands of sphygmomanometers have highlighted inconsistencies and variations in measurements. These reliability issues have significantly lowered the confidence of healthcare practitioners in dependable functioning of many sphygmomanometer brands, thus, hampering the market development over the forecasted period.

Market Opportunities: Growing awareness of blood pressure

Growing awareness about the serious health implications of uncontrolled high blood pressure globally presents a major opportunity for the sphygmomanometer market. High blood pressure is a growing public health concern worldwide as it significantly increases the risks of heart diseases, strokes, kidney failures and other serious health issues. Increasing screening and regular monitoring of blood pressure levels has become crucial as the prevalence of hypertension increases, thus, creating lucrative growth opportunities for market development over the forecasted period.

Discover high revenue pocket segments and roadmap to it: Get instant access to report

Type segment is sub-segmented into  mercury sphygmomanometer, aneroid sphygmomanometer, and digital sphygmomanometer. Digital sphygmomanometer segment is anticipated to hold 59.4% of the market share in 2024. Digital devices provide precise readings, helping clinicians and patients alike get an accurate assessment of blood pressure levels and trends over time. The digital displays make it easy to read measurements without having to parse fluctuating mercury levels. This convenience supports compliance for patients who need to monitor their pressure regularly at home. This data collection enables physicians to better diagnose issues and track the efficacy of treatments over long periods. The stored readings alleviate issues of measurement inaccuracies that can occur with manual methods based on human error. Some digital devices even support wireless data transmission to patient portals or physician offices for remote monitoring capabilities. This remote monitoring allows higher risk individuals to have their pressure checked regularly without visiting in-person for each reading.

Insights, By Operation: Increase in the usage of automated sphygmomanometer

Operation segment is sub-segmented into manual, semi-automatic, and automatic. Automatic segment is estimated to contribute the highest share of the sphygmomanometer market and is projected to hold 55.1% of the market share in 2024. Automatic devices inflate and deflate the cuff automatically to determine systolic and diastolic pressure values based on auscultatory or oscillometric methods. This autonomy removes human errors that can occur with inaccurate listening skills, cuff placement issues or inconsistent pump pressures used in manual modes. Automatic measurements are especially valuable in clinical settings where healthcare workers need to capture many readings efficiently. The push-button functionality enables teams to quickly record patients' pressures and move on to other duties without wasting time on repetitive manual pumping and listening tasks. This automation allows more patients to be serviced within tight examination windows.

Insights, By Modality: Convenience drives portability segment

Modality segment is sub-segmented into wall mounted, portable, and others. Portable segment is estimated to contribute the highest share of the sphygmomanometer market and is projected to hold 48.3% of the market share in 2024. Unlike wall-mounted units restricted to clinical settings, portable models afford users independence to check and keep track of their numbers while on the go. Whether it is in the comfort of their own home or away at work/travel, portables empower individuals to adhere to a self-monitoring regimen without having to visit doctor offices or stores each time. This boosts compliance for managing high blood pressure proactively. With rechargeable batteries and compact designs, portables are truly mobile companions that easily fit in purses and bags. For healthcare professionals, portables also improve the accessibility of screening. Their lightweight construction allows blood pressure to be assessed anywhere patient care is administered - even outside of traditional clinical spaces.

Regional Insights

To learn more about this report, request sample copy

The North American region currently dominates the global sphygmomanometer market and is anticipated to contribute 41.6% of the market share in 2024. This can be attributed to several factors. The high healthcare expenditures in countries like the U.S. and Canada have translated to greater adoption of advanced medical devices including automated blood pressure monitors. Moreover, the presence of leading medical device companies in the region has ensured steady supply of innovative products. These companies have also engaged in strategic collaborations and partnerships to strengthen their distribution networks across the region. Growing instances of lifestyle diseases like hypertension have created a constant demand for sphygmomanometers from both hospitals as well as households. Favorable reimbursement policies have further encouraged patients to regularly monitor their blood pressure.

The Asia Pacific region has emerged as the fastest growing market for sphygmomanometers in recent times. This growth can be attributed to rising healthcare expenditures of developing countries in South East Asia. Rising incomes have improved access to advanced medical treatments. There is also a growing focus on preventive healthcare approaches to control diseases. This has augmented the sales of home-use blood pressure monitors. Rapid urbanization in countries like China and India has led to growing prevalence of sedentary lifestyle diseases. This has necessitated regular screening and monitoring of blood pressure levels both in healthcare facilities as well as households. Local manufacturing of affordable sphygmomanometers by Chinese and Indian companies has further fueled market penetration.

Market Report Scope

Sphygmomanometer Industry News

• On February 27, 2024, Aktiia, a Switzerland-based health tech innovator, announced the completion of a USD 30 MN (CHF 27 MN) investment round headed by Redalpine. This strategic capital infusion will help Aktiia accelerate its objective to reduce the global burden of hypertension by offering revolutionary insights into blood pressure management via AI-driven technology, which is already used by over 60,000 customers and dozens of healthcare organizations.
• On January 04, 2024, Nanowear, a leader in healthcare-at-home remote diagnostics, announced that SimpleSense, its nanotechnology-enabled wearable and software platform, had been granted U.S. FDA 510(k) approval for a revolutionary AI-enabled Software-as-a-Medical Device (SaMD). SimpleSense-BP, the first non-invasive, cuffless, continuous blood pressure monitor and diagnostic, is a transformative tool in clinical diagnostic management of hypertension and complements the wearable platforms previously cleared cardiopulmonary diagnostics.
• In January 2023, iProven, a leading manufacturer of healthcare devices, announced the launch of the BPM-417 Blood Pressure Monitor, a revolutionary device with a number of innovative features that allow users to effortlessly monitor and track their blood pressure. One of the BPM-417's notable features is its wrist guide position, which assists users in properly positioning their wrist for precise readings.
• In May 2021, Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced the launch of its new wearable and continuous ambulatory blood pressure monitoring (ABPM) chest monitor. Biobeat's disposable wearable chest monitor is an easy and intuitive patient self-setup that requires no assistance from a clinician or professional.

*Definition: Sphygmomanometer Market involves the manufacturing and sale of sphygmomanometers, devices that are used for measuring blood pressure. It includes companies that produce both mercury and aneroid (manual and digital) sphygmomanometers for clinical use in hospitals, private clinics, and doctors' offices as well as home use. The market has been growing steadily due to the rising prevalence of cardiovascular diseases and hypertension worldwide that has increased the demand for regular blood pressure monitoring devices.

Market Segmentation

•  Type Insights (Revenue, USD BN, 2019 - 2031)
  • Mercury Sphygmomanometer
  • Aneroid Sphygmomanometer
  • Digital Sphygmomanometer
•  Operation Insights (Revenue, USD BN, 2019 - 2031)
  • Manual
  • Semi-Automatic
  • Automatic
•  Modality Insights (Revenue, USD BN, 2019 - 2031)
  • Wall Mounted
  • Portable
  • Others
•  End User Insights (Revenue, USD BN, 2019 - 2031)
  • Hospitals & Clinics
  • Homecare Settings
  • Ambulatory Surgical Centres
  • Others
• Regional Insights (Revenue, USD BN, 2019 - 2031)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Omron Healthcare
  • ICU Medical Inc.
  • Koninklijke Philips N.V.
  • Baxter
  • Nihon Kohden
  • A&D Medical
  • Spengler
  • SunTech Medical
  • Rudolf Riester GmbH
  • Microlife Corporation
  • American Diagnostic Corporation
  • Panasonic Healthcare
  • Beurer
  • Rossmax International Ltd.
  • PAUL HARTMANN
  • BPL Medical Technologies
  • Homedics
  • Glanbia PLC